A Prospective Cohort Study of Neoadjuvant Chemotherapy Plus Sintillumab in the Treatment of Resectable NSCLC
Clinical trial NCT06485557 · UNKNOWN
Trial details
- NCT number
- NCT06485557
- Sponsor
- Tang-Du Hospital
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-01
- Primary completion
- 2025-12-31
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.